• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committeee and Drug Safety and Risk Management Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

FDA
 
Disclaimer 
 
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
 
 
FDA Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee (PDF - 20MB)
 
 
 Xanodyne Pharmaceuticals, Inc. & Qualitest/Vintage Pharmaceuticals
 
Disclaimer
 
The statements contained in this document(s) are those of the product's sponsors, not FDA, and FDA does not necessarily agree with the sponsors’ statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
 
 
Sponsor Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee (PDF - 248KB)